Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice Experiment.

Autor: Schein J; Otsuka Pharmaceutical Development and Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA., Cloutier M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Gauthier-Loiselle M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Catillon M; Analysis Group, Inc., 151 West 42nd Street, 23rd Floor, New York, NY, 10036, USA. maryaline.catillon@analysisgroup.com., Meng Y; Analysis Group, Inc., 1 Angel Court, 14th Floor, London, EC2R 7HJ, UK., Libchaber B; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Jiang F; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Childress A; Center for Psychiatry and Behavioral Medicine, 7351 Prairie Falcon Rd STE 160, Las Vegas, NV, 89128, USA.

Publikováno v: Neurology and therapy [Neurol Ther] 2024 Nov 16. Date of Electronic Publication: 2024 Nov 16.

Intravenous lidocaine for postoperative analgesia management in paediatrics: A systematic review with meta-analysis of published studies.

Autor: Pardessus P; From the University of Paris-Cité (PP, ML, KB, A-LH, BB, YM, ML, MD, FJ-M, SD), Department of Anaesthesia and Intensive Care (PP, ML, KB, A-LH, BB, YM, ML, MD, FJ-M, SD), FHU I2D2, Robert Debré University Hospital, Paris, France (PP, ML, KB, A-LH, BB, YM, ML, MD, FJ-M, SD)., Loiselle M, Brouns K, Horlin AL, Bruneau B, Maroun Y, Lagarde M, Deliere M, Julien-Marsollier F, Dahmani S

Publikováno v: European journal of anaesthesiology [Eur J Anaesthesiol] 2024 Nov 01; Vol. 41 (11), pp. 856-864. Date of Electronic Publication: 2024 Jul 29.

A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy.

Autor: Schein J; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ 08540, USA., Cloutier M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Gauthier-Loiselle M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Catillon M; Analysis Group, Inc., 151 West 42nd Street, 23rd Floor, New York, NY 10036, USA., Xu C; Analysis Group, Inc., 151 West 42nd Street, 23rd Floor, New York, NY 10036, USA., Qu A; Analysis Group, Inc., 151 West 42nd Street, 23rd Floor, New York, NY 10036, USA., Lee F; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Childress A; Center for Psychiatry & Behavioral Medicine, 7351 Prairie Falcon Rd STE 160, Las Vegas, NV 89128, USA.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2024 Sep; Vol. 13 (9), pp. e240089. Date of Electronic Publication: 2024 Aug 12.

Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort study.

Autor: Schein J; Otsuka Pharmaceutical Development and Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA., Cloutier M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Gauthier-Loiselle M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Bungay R; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada. Rebecca.Bungay@analysisgroup.com., Chen K; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Chan D; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Guerin A; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Childress A; Center for Psychiatry and Behavioral Medicine, 7351 Prairie Falcon Rd STE 160, Las Vegas, NV, 89128, USA.

Publikováno v: Child and adolescent psychiatry and mental health [Child Adolesc Psychiatry Ment Health] 2024 Jul 08; Vol. 18 (1), pp. 80. Date of Electronic Publication: 2024 Jul 08.

Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.

Autor: Schein J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ., Cloutier M; Analysis Group, Inc., Montréal, QC, Canada., Gauthier-Loiselle M; Analysis Group, Inc., Montréal, QC, Canada., Bungay R; Analysis Group, Inc., Montréal, QC, Canada., Chen K; Analysis Group, Inc., Montréal, QC, Canada., Chan D; Analysis Group, Inc., Montréal, QC, Canada., Childress A; Center for Psychiatry and Behavioral Medicine, Las Vegas, NV.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Jun; Vol. 30 (6), pp. 588-598.